Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Geroldi

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Diabetes Care|August 1, 1995
Lipoprotein(a), apolipoprotein(a) polymorphism, and insulin treatment in type II diabetic patientsP Buscaglia, C Gazzaruso, A Garzaniti, et al.
Mechanisms of Ageing and Development|September 1, 1989
Enzyme activities in perikaryal and synaptic mitochondrial fractions from rat hippocampus during developmentR F Villa, A Gorini, D Geroldi, et al.
Thrombosis and Haemostasis|June 24, 1985
LAV antibodies and IgG subclasses in haemophiliaD Geroldi, A Plebani, G Gamba, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 29, 2008
Decreased plasma levels of soluble receptor for advanced glycation end products in mild cognitive impairmentR Ghidoni, L Benussi, M Glionna, et al.
Thrombosis and Haemostasis|October 1, 1981
Enhanced antithrombotic mechanisms in patients with maturity-onset diabetes mellitus without thromboembolic complicationsG Grignani, G Gamba, D Geroldi, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 30, 1993
Characterization of apo(a) polymorphism by a modified immunoblotting technique in an Italian population sampleD Geroldi, V Bellotti, P Buscaglia, et al.
Infection|September 1, 1985
Epidemic of LAV/HTLV III infection in drug addicts in Milan: serological survey and clinical follow-upA Lazzarin, M Galli, D Geroldi, et al.
International Journal of Cardiology|July 22, 1998
Apolipoprotein(a) phenotypes as genetic markers of coronary atherosclerosis severityC Gazzaruso, D Geroldi, A Garzaniti, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 24, 2004
Apolipoprotein(a) size polymorphism is associated with coronary heart disease in polygenic hypercholesterolemiaE Emanuele, E Peros, P Minoretti, et al.
Haematologica|September 1, 1984
Mitral valve prolapse and Factor VIII complex abnormalitiesG Gamba, A Venco, A Grandi, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Diabetes Care|August 1, 1995
Lipoprotein(a), apolipoprotein(a) polymorphism, and insulin treatment in type II diabetic patientsP Buscaglia, C Gazzaruso, A Garzaniti, et al.
Mechanisms of Ageing and Development|September 1, 1989
Enzyme activities in perikaryal and synaptic mitochondrial fractions from rat hippocampus during developmentR F Villa, A Gorini, D Geroldi, et al.
Thrombosis and Haemostasis|June 24, 1985
LAV antibodies and IgG subclasses in haemophiliaD Geroldi, A Plebani, G Gamba, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 29, 2008
Decreased plasma levels of soluble receptor for advanced glycation end products in mild cognitive impairmentR Ghidoni, L Benussi, M Glionna, et al.
Thrombosis and Haemostasis|October 1, 1981
Enhanced antithrombotic mechanisms in patients with maturity-onset diabetes mellitus without thromboembolic complicationsG Grignani, G Gamba, D Geroldi, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 30, 1993
Characterization of apo(a) polymorphism by a modified immunoblotting technique in an Italian population sampleD Geroldi, V Bellotti, P Buscaglia, et al.
Infection|September 1, 1985
Epidemic of LAV/HTLV III infection in drug addicts in Milan: serological survey and clinical follow-upA Lazzarin, M Galli, D Geroldi, et al.
International Journal of Cardiology|July 22, 1998
Apolipoprotein(a) phenotypes as genetic markers of coronary atherosclerosis severityC Gazzaruso, D Geroldi, A Garzaniti, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 24, 2004
Apolipoprotein(a) size polymorphism is associated with coronary heart disease in polygenic hypercholesterolemiaE Emanuele, E Peros, P Minoretti, et al.
Haematologica|September 1, 1984
Mitral valve prolapse and Factor VIII complex abnormalitiesG Gamba, A Venco, A Grandi, et al.
Pageof 5